Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients

Chest

Volumn 114, Issue 1, 1998, Pages 138-145

  El Solh, Ali A ^b   Nopper, Julie ^b   Abul Khoudoud, Mohamad R ^b   Sherif, Sherif M ^b   Aquilina, Alan T ^b   Grant, Brydon J B ^a  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

AIDS; Outcome; Uncommon nontuberculous mycobacterium

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; HUMAN TISSUE; LUNG INFILTRATE; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MALE; MYCOBACTERIUM; MYCOBACTERIUM XENOPEI; PRIORITY JOURNAL; RADIOGRAPHY;

EID: 0031848728     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.1.138     Document Type: Article

References (26)

1. O'Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial diseases in the United States. Am Rev Respir Dis 1987; 135:1007-14
2. Costrini AM, Mahler DA, Gross WM, et al. Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. Am Rev Respir Dis 1981; 123:104-09
3. Choudhri S, Manfreda J, Wolfe J, et al. Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis 1995; 21:128-33
4. Murray JF, Garay SM, Hopewell PC, et al. Pulmonary complications of the acquired immunodeficiency syndrome: an update: report of the Second National Heart, Lung, and Blood Institute Workshop. Am Rev Respir Dis 1987; 135: 504-09
5. Teirstein AS, Pamsker B, Kirschner PA, et al. Pulmonary infection with Mycobacterium avium-intracellulare: diagnosis, clinical patterns, treatment (clinical conference). Mt Sinai J Med 1990; 57:209-15
6. Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus infection. Ann Intern Med 1991; 114:861-68
7. Zaugg M, Salfinger M, Opravil M, et al. Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review. Clin Infect Dis 1993; 15:540-48
8. Barber TW, Craven DE, Farber HW. Mycobacterium gordonae: a possible opportunistic respiratory tract pathogen in patients with advanced human immunodeficiency virus, type 1 infection. Chest 1991; 100:716-20
9. Claydon EJ, Coker RJ, Harris JRW. Mycobacterium malmoense infection in HIV positive patients. J Infect 1991; 23:191-94
10. Lambert GW, Baddour LM. Right middle lobe syndrome caused by Mycobacterium fortuitum in a patient with human immunodeficiency virus infection. South Med J 1992; 85: 767-69
11. Center for Infectious Disease. Impact of the expanded AIDS surveillance case definition on AIDS case reporting. MMWR 1993; 42:308-10
12. Wallace RT Jr, O'Brian R, Glassroth J, et al. Diagnosis and treatment of disease caused by nontuberculous mycobacteria (official ATS statement). Am Rev Respir Dis 1990; 142: 940-53
13. Horsburgh RC Jr, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1989; 139:4-7
14. Rothman KJ. Modern epidemiology. Boston: Little Brown, 1986
15. Griffith DE, Girard WM, Wallace RW Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. Am Rev Respir Dis 1993; 147:1271-78
16. Banks J, Hunter AM, Campbell A, et al. Pulmonary infection with Mycobacterium xenopi: review of treatment and response. Thorax 1984; 39:376-82
17. Shafer RW, Sierra MF. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii and other nontuberculous mycobacteria in an area of endemicity for AIDS. Clin Infect Dis 1992; 15:161-62
18. Modilevsky T, Sattler FR, Barnes PF. Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med 1989; 149:2201-05
19. Fauci AS, Macher AM, Longo DL, et al. NIH conference: acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic and therapeutic considerations. Ann Intern Med 1984; 100:92-106
20. Wallace RJ Jr. The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M fortuitum and M chelonae. Clin Chest Med 1989; 10:419-29
21. Rigsby MO, Curtis AM. Pulmonary disease from nontuberculous mycobacteria in patients with human immunodeficiency virus. Chest 1994; 106:913-19
22. Marinelli DL, Albelda SM, Williams TM, et al. Nontuberculous mycobacterial infection in AIDS: clinical, pathologic, and radiographic features. Radiology 1986; 160:77-82
23. Schraufnagel DE, Leech JA, Polak B. Mycobacterium kansasii: colonization and disease. Br J Dis Chest 1986; 80:131-37
24. Horshburgh CR Jr, Havlik JA, Ellis DA, et al. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis 1991; 144:557-59
25. Pechere M, Opravil M, Wald A, et al. Clinical and epidemiologic features of infection with Mycbacterium genavense. Arch Intern Med 1995; 155:400-04
26. American Thoracic Society. Diagnosis and treatment of disease caused by the nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156:81-25